Rapport Therapeutics Common Stock Performance

Rapport Therapeutics Relative Risk vs. Return Landscape

If you would invest  2,511  in Rapport Therapeutics Common on November 15, 2025 and sell it today you would earn a total of  282.00  from holding Rapport Therapeutics Common or generate 11.23% return on investment over 90 days. Rapport Therapeutics Common is currently generating 0.2349% in daily expected returns and assumes 3.4982% risk (volatility on return distribution) over the 90 days horizon. In different words, 31% of stocks are less volatile than Rapport, and 96% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.Given the investment horizon of 90 days Rapport Therapeutics is expected to generate 4.54 times more return on investment than the market. However, the company is 4.54 times more volatile than its market benchmark. It trades about 0.07 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.13 per unit of risk.

Rapport Therapeutics Target Price Odds to finish over Current Price

Given the investment horizon of 90 days Rapport Therapeutics has a beta of 0.62 indicating as returns on the market go up, Rapport Therapeutics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Rapport Therapeutics Common will be expected to be much smaller as well. Additionally Rapport Therapeutics Common has an alpha of 0.1834, implying that it can generate a 0.18 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).

Predictive Modules for Rapport Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Rapport Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 24.74 28.24 31.74 Details

Intrinsic Valuation Low Real High 25.15 32.72 36.22 Details

5 Analysts Consensus Low Target High 46.61 51.22 56.86 Details

Earnings Estimates (0) Low Projected EPS High -0.81 -0.76 -0.7 Details

Rapport Therapeutics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Rapport Therapeutics is not an exception. The market had few large corrections towards the Rapport Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Rapport Therapeutics Common, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Rapport Therapeutics within the framework of very fundamental risk indicators.

Rapport Therapeutics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Rapport Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Rapport Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

Rapport Therapeutics Price Density Drivers

Rapport Therapeutics Fundamentals Growth

When running Rapport Therapeutics' price analysis, check to measure Rapport Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rapport Therapeutics is operating at the current time. Most of Rapport Therapeutics' value examination focuses on studying past and present price action to predict the probability of Rapport Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rapport Therapeutics' price. Additionally, you may evaluate how the addition of Rapport Therapeutics to your portfolios can decrease your overall portfolio volatility.